Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft linesMichelle J. Clarke, Jann N. Sarkaria, Evan A. Mulligan et al.|Molecular Cancer Therapeutics|2009Cited by 94